{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:22:01Z","timestamp":1794320521424,"version":"4.9.0"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Carbonic anhydrase IX (CAIX) is a hypoxia and HIF-1\u2013inducible protein that regulates intra- and extracellular pH under hypoxic conditions and promotes tumor cell survival and invasion in hypoxic microenvironments. Interrogation of 3,630 human breast cancers provided definitive evidence of CAIX as an independent poor prognostic biomarker for distant metastases and survival. shRNA-mediated depletion of CAIX expression in 4T1 mouse metastatic breast cancer cells capable of inducing CAIX in hypoxia resulted in regression of orthotopic mammary tumors and inhibition of spontaneous lung metastasis formation. Stable depletion of CAIX in MDA-MB-231 human breast cancer xenografts also resulted in attenuation of primary tumor growth. CAIX depletion in the 4T1 cells led to caspase-independent cell death and reversal of extracellular acidosis under hypoxic conditions in vitro. Treatment of mice harboring CAIX-positive 4T1 mammary tumors with novel CAIX-specific small molecule inhibitors that mimicked the effects of CAIX depletion in vitro resulted in significant inhibition of tumor growth and metastasis formation in both spontaneous and experimental models of metastasis, without inhibitory effects on CAIX-negative tumors. Similar inhibitory effects on primary tumor growth were observed in mice harboring orthotopic tumors comprised of lung metatstatic MDA-MB-231 LM2-4Luc+ cells. Our findings show that CAIX is vital for growth and metastasis of hypoxic breast tumors and is a specific, targetable biomarker for breast cancer metastasis. Cancer Res; 71(9); 3364\u201376. \u00a92011 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-10-4261","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T23:13:44Z","timestamp":1300403624000},"page":"3364-3376","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":696,"title":["Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors"],"prefix":"10.1158","volume":"71","author":[{"given":"Yuanmei","family":"Lou","sequence":"first","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arusha","family":"Oloumi","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Chia","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ostlund","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardalan","family":"Ahmadi","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Kyle","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"auf dem Keller","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Leung","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Huntsman","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"},{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaise","family":"Clarke","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"},{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent W.","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Waterhouse","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Bally","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Roskelley","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Overall","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Minchinton","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pacchiano","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Carta","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Scozzafava","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Touisni","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Winum","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoukat","family":"Dedhar","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"},{"name":"Authors' Affiliations: Departments of 1Integrative Oncology, 2Medical Oncology, 3Centre for Translational and Applied Genomics, 4Experimental Therapeutics, BC Cancer Research Centre and BC Cancer Agency; Departments of 5Biochemistry and Molecular Biology and 6Cell and Physiological Sciences, University of British Columbia; 7Genetic Pathology Evaluation Centre, Vancouver, British Columbia; 8Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada; 9Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy; and 10Institut des Biomol\u00e9cules Max Mousseron, UMR 5247 CNRS, Universit\u00e9 Montpellier 1 & 2, Ecole Nationale Sup\u00e9rieure de Chimie de Montpellier, 8 Rue de l'Ecole Normale, 34296 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2011,4,29]]},"reference":[{"key":"2022061702450209100_bib1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2022061702450209100_bib2","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1158\/1078-0432.CCR-06-2971","article-title":"Hypoxia and metastasis","volume":"13","author":"Chaudary","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2022061702450209100_bib3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00109-007-0281-3","article-title":"Hypoxia and cancer","volume":"85","author":"Brahimi-Horn","year":"2007","journal-title":"J Mol Med"},{"key":"2022061702450209100_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/BD-2007-26105","article-title":"Hypoxia and metastasis in breast cancer","volume":"26","author":"Chaudary","year":"2006","journal-title":"Breast Dis"},{"key":"2022061702450209100_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm1764","article-title":"Stromal gene expression predicts clinical outcome in breast cancer","volume":"14","author":"Finak","year":"2008","journal-title":"Nat Med"},{"key":"2022061702450209100_bib6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","article-title":"Tumor cell metabolism: cancer's Achilles' heel","volume":"13","author":"Kroemer","year":"2008","journal-title":"Cancer Cell"},{"key":"2022061702450209100_bib7","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061702450209100_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"2022061702450209100_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00428-010-0938-0","article-title":"Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX","volume":"457","author":"Chen","year":"2010","journal-title":"Virchows Arch"},{"key":"2022061702450209100_bib10","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/sj.bjc.6605702","article-title":"Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype","volume":"102","author":"Kristiansen","year":"2010","journal-title":"Br J Cancer"},{"key":"2022061702450209100_bib11","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2001.19.16.3660","article-title":"Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma","volume":"19","author":"Chia","year":"2001","journal-title":"J Clin Oncol"},{"key":"2022061702450209100_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.bjc.6603530","article-title":"Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer","volume":"96","author":"Hussain","year":"2007","journal-title":"Br J Cancer"},{"key":"2022061702450209100_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.nucmedbio.2010.02.006","article-title":"Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia","volume":"37","author":"Akurathi","year":"2010","journal-title":"Nucl Med Biol"},{"key":"2022061702450209100_bib14","doi-asserted-by":"crossref","first-page":"e10857","DOI":"10.1371\/journal.pone.0010857","article-title":"Molecular targeting of carbonic anhydrase IX in mice with hypoxic HT29 colorectal tumor xenografts","volume":"5","author":"Carlin","year":"2010","journal-title":"PLoS One"},{"key":"2022061702450209100_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.radonc.2009.06.019","article-title":"Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model","volume":"92","author":"Dubois","year":"2009","journal-title":"Radiother Oncol"},{"key":"2022061702450209100_bib16","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ijc.11142","article-title":"Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma","volume":"105","author":"Chrastina","year":"2003","journal-title":"Int J Cancer"},{"key":"2022061702450209100_bib17","first-page":"13","article-title":"Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody","volume":"50","author":"Chrastina","year":"2003","journal-title":"Neoplasma"},{"key":"2022061702450209100_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jcp.22400","article-title":"pH control mechanisms of tumor survival and growth","volume":"226","author":"Parks","year":"2011","journal-title":"J Cell Physiol"},{"key":"2022061702450209100_bib19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00424-009-0677-8","article-title":"Protons make tumor cells move like clockwork","volume":"458","author":"Stock","year":"2009","journal-title":"Pflugers Arch"},{"key":"2022061702450209100_bib20","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1038\/onc.2010.455","article-title":"New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation","volume":"29","author":"Swietach","year":"2010","journal-title":"Oncogene"},{"key":"2022061702450209100_bib21","doi-asserted-by":"crossref","first-page":"20299","DOI":"10.1074\/jbc.M109.006478","article-title":"The role of carbonic anhydrase 9 in regulating extracellular and intracellular ph in three-dimensional tumor cell growths","volume":"284","author":"Swietach","year":"2009","journal-title":"J Biol Chem"},{"key":"2022061702450209100_bib22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res"},{"key":"2022061702450209100_bib23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/13543776.2010.484803","article-title":"Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007\u20132009","volume":"20","author":"Poulsen","journal-title":"Expert Opin Ther Pat"},{"key":"2022061702450209100_bib24","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.bmcl.2009.06.022","article-title":"In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives","volume":"19","author":"Ahlskog","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"2022061702450209100_bib25","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/dvdy.21658","article-title":"Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis","volume":"237","author":"Lou","year":"2008","journal-title":"Dev Dyn"},{"key":"2022061702450209100_bib26","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1158\/0008-5472.CAN-07-5869","article-title":"Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival","volume":"68","author":"McDonald","year":"2008","journal-title":"Cancer Res"},{"key":"2022061702450209100_bib27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2009.01.021","article-title":"Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis","volume":"15","author":"Ebos","year":"2009","journal-title":"Cancer Cell"},{"key":"2022061702450209100_bib28","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1021\/jm0501073","article-title":"Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors","volume":"48","author":"Cecchi","year":"2005","journal-title":"J Med Chem"},{"key":"2022061702450209100_bib29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.radonc.2007.04.018","article-title":"Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors","volume":"83","author":"Dubois","year":"2007","journal-title":"Radiother Oncol"},{"key":"2022061702450209100_bib30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastova","year":"2004","journal-title":"FEBS Lett"},{"key":"2022061702450209100_bib31","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1158\/1078-0432.CCR-07-4465","article-title":"Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenografts","volume":"14","author":"Baker","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2022061702450209100_bib32","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1158\/1078-0432.CCR-06-1941","article-title":"Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors","volume":"13","author":"Kyle","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2022061702450209100_bib33","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"Cheang","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"2022061702450209100_bib34","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.humpath.2007.10.026","article-title":"Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma","volume":"39","author":"Choi","year":"2008","journal-title":"Hum Pathol"},{"key":"2022061702450209100_bib35","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/bcr1847","article-title":"Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study","volume":"10","author":"Crabb","year":"2008","journal-title":"Breast Cancer Res"},{"key":"2022061702450209100_bib36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.lungcan.2006.08.017","article-title":"Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma","volume":"54","author":"Kon-no","year":"2006","journal-title":"Lung Cancer"},{"key":"2022061702450209100_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bjc.6604844","article-title":"The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy","volume":"100","author":"Tan","year":"2009","journal-title":"Br J Cancer"},{"key":"2022061702450209100_bib38","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res"},{"key":"2022061702450209100_bib39","first-page":"1399","article-title":"Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor","volume":"52","author":"Aslakson","year":"1992","journal-title":"Cancer Res"},{"key":"2022061702450209100_bib40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.bjc.6605491","article-title":"Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype","volume":"102","author":"Ameri","year":"2010","journal-title":"Br J Cancer"},{"key":"2022061702450209100_bib41","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1158\/0008-5472.CAN-03-2224","article-title":"Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion","volume":"64","author":"Robertson","year":"2004","journal-title":"Cancer Res"},{"key":"2022061702450209100_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1464-410X.2008.07642.x","article-title":"Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia","volume":"101 Suppl 4","author":"Pastorekova","year":"2008","journal-title":"BJU Int"},{"key":"2022061702450209100_bib43","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1172\/JCI36579","article-title":"Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis","volume":"119","author":"Galluzzo","year":"2009","journal-title":"J Clin Invest"},{"key":"2022061702450209100_bib44","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/07357900802653464","article-title":"Expression and activity of carbonic anhydrase IX is associated with metabolic dysfunction in MDA-MB-231 breast cancer cells","volume":"27","author":"Li","year":"2009","journal-title":"Cancer Invest"},{"key":"2022061702450209100_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.advenzreg.2009.10.005","article-title":"Membrane-bound carbonic anhydrases are key pH regulators controlling tumor growth and cell migration","volume":"50","author":"Chiche","year":"2010","journal-title":"Adv Enzyme Regul"},{"key":"2022061702450209100_bib46","doi-asserted-by":"crossref","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","author":"Pacchiano","year":"2011","journal-title":"J Med Chem"},{"key":"2022061702450209100_bib47","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1021\/jm030911u","article-title":"Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates","volume":"46","author":"Winum","year":"2003","journal-title":"J Med Chem"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/71\/9\/3364\/2666164\/3364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/71\/9\/3364\/2666164\/3364.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T07:15:56Z","timestamp":1655450156000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/71\/9\/3364\/575450\/Targeting-Tumor-Hypoxia-Suppression-of-Breast"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,29]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,4,29]]},"published-print":{"date-parts":[[2011,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-10-4261","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22389692.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389686.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389683.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389677.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6502688","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389674","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389686","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389674.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6502688.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389680.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389677","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389689","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389689.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389680","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389692","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389683","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,29]]}}}